Regional Anesthesia & Pain Medicine,
Journal Year:
2023,
Volume and Issue:
49(4), P. 233 - 240
Published: July 25, 2023
Introduction
Chronic
pain
patients
may
experience
impairments
in
multiple
health-related
domains.
The
design
and
interpretation
of
clinical
trials
chronic
interventions,
however,
remains
primarily
focused
on
treatment
effects
intensity.
This
study
investigates
a
novel,
multidimensional
holistic
response
to
evoked
compound
action
potential-controlled
closed-loop
versus
open-loop
spinal
cord
stimulation
as
well
the
degree
neural
activation
that
produced
response.
Methods
Outcome
data
for
intensity,
physical
function,
quality
life,
sleep
emotional
function
were
derived
from
individual
patient
level
EVOKE
multicenter,
participant,
investigator,
outcome
assessor-blinded,
parallel-arm
randomized
controlled
trial
with
24
month
follow-up.
Evaluation
considered
whether
baseline
score
was
worse
than
normative
values
minimal
important
differences
reached
each
domains
impaired
at
baseline.
A
cumulative
responder
calculated
reflect
total
accumulated
across
all
Objective
neurophysiological
data,
including
measured.
Results
Patients
(n=67)
or
(n=67).
greater
proportion
(49.3%
vs
26.9%)
responders
24-month
follow-up,
least
one
difference
(absolute
risk
difference:
22.4%,
95%
CI
6.4%
38.4%,
p=0.012).
significantly
time
points
resulted
achievement
more
three
additional
follow-up
(mean
3.4,
1.3
5.5,
p=0.002).
Neural
times
accurate
(p<0.001
points).
Conclusion
results
this
suggest
can
provide
sustained
clinically
meaningful
improvements
improvement
long-term
refractory
pain.
Trial
registration
number
NCT02924129
.
Journal of Clinical Medicine,
Journal Year:
2020,
Volume and Issue:
9(12), P. 4131 - 4131
Published: Dec. 21, 2020
Despite
the
proven
clinical
value
of
spinal
cord
stimulation
(SCS)
for
patients
with
failed
back
surgery
syndrome
(FBSS),
factors
related
to
a
successful
SCS
outcome
are
not
yet
clearly
understood.
This
study
aimed
predict
responders
high
frequency
at
10
kHz
(HF-10).
Data
before
implantation
and
last
available
data
was
extracted
119
FBSS
treated
HF-10
SCS.
Correlations,
logistic
regression,
linear
discriminant
analysis,
classification
regression
trees,
random
forest,
bagging,
boosting
were
applied.
Based
on
feature
selection,
trial
pain
relief,
predominant
location,
number
previous
surgeries
relevant
predicting
relief.
To
50%
58.33%
accuracy
obtained
boosting,
forest
bagging.
For
30%
70.83%
using
trees.
medication
decrease,
accuracies
above
80%
analysis.
Several
machine
learning
techniques
able
an
acceptable
accuracy.
However,
none
revealed
The
inconsistent
results
regarding
predictive
in
literature,
combined
currently
models,
might
suggest
that
routinely
collected
baseline
parameters
from
practice
sufficient
consistently
response
long-term.
Regional Anesthesia & Pain Medicine,
Journal Year:
2021,
Volume and Issue:
46(4), P. 293 - 297
Published: Jan. 21, 2021
Spinal
cord
stimulation
is
frequently
used
for
the
treatment
of
intractable
chronic
pain
conditions.
Trialing
spinal
stimulator
device
recommended
to
assess
patient's
response
neurostimulation
before
permanent
implantation.
The
trial
often
assessed
by
Numeric
Rating
Scale
changes
and
patient-reported
percentage
improvement.
Using
number
rating
scale
between
prespinal
postspinal
trial,
a
calculated
improvement
can
be
obtained.
aim
this
study
was
difference
in
during
trials.This
retrospective
single
center
review
all
trials
from
January
1
2017
July
2019.
A
total
174
patients
were
included.
paired
t-test
compare
numeric
scores
obtained
prestimulation
versus
poststimulation.
mean
methods
(patient-reported
minus
calculated)
compared
with
zero
using
1-sample
t-test.
Lin's
concordance
correlation
coefficient
computed
95%
CI,
Fisher
z-transformation;
bootstrapping
approach
groups.
In
cases,
two-tailed
tests
p<0.05
considered
statistically
significant.Based
on
poststimulation
scores,
mean±SD
54±28.
59±25.
overall
limits
agreement
two
are
-30%
+41%.
0.76
(95%
CI
0.69
0.81).Although
highly
correlated,
there
substantial
lack
scale,
suggesting
that
these
measures
should
not
interchangeably
outcome
assessment.
This
emphasizes
need
improved
metrics
better
measure
patient
neuromodulation
therapies.
Additionally,
found
higher
than
pain,
potentially
highlighting
multidimensional
experience
unpredictability
solely
outcomes.
Regional Anesthesia & Pain Medicine,
Journal Year:
2023,
Volume and Issue:
49(4), P. 233 - 240
Published: July 25, 2023
Introduction
Chronic
pain
patients
may
experience
impairments
in
multiple
health-related
domains.
The
design
and
interpretation
of
clinical
trials
chronic
interventions,
however,
remains
primarily
focused
on
treatment
effects
intensity.
This
study
investigates
a
novel,
multidimensional
holistic
response
to
evoked
compound
action
potential-controlled
closed-loop
versus
open-loop
spinal
cord
stimulation
as
well
the
degree
neural
activation
that
produced
response.
Methods
Outcome
data
for
intensity,
physical
function,
quality
life,
sleep
emotional
function
were
derived
from
individual
patient
level
EVOKE
multicenter,
participant,
investigator,
outcome
assessor-blinded,
parallel-arm
randomized
controlled
trial
with
24
month
follow-up.
Evaluation
considered
whether
baseline
score
was
worse
than
normative
values
minimal
important
differences
reached
each
domains
impaired
at
baseline.
A
cumulative
responder
calculated
reflect
total
accumulated
across
all
Objective
neurophysiological
data,
including
measured.
Results
Patients
(n=67)
or
(n=67).
greater
proportion
(49.3%
vs
26.9%)
responders
24-month
follow-up,
least
one
difference
(absolute
risk
difference:
22.4%,
95%
CI
6.4%
38.4%,
p=0.012).
significantly
time
points
resulted
achievement
more
three
additional
follow-up
(mean
3.4,
1.3
5.5,
p=0.002).
Neural
times
accurate
(p<0.001
points).
Conclusion
results
this
suggest
can
provide
sustained
clinically
meaningful
improvements
improvement
long-term
refractory
pain.
Trial
registration
number
NCT02924129
.